Literature DB >> 19862763

Proteome changes in human bronchoalveolar cells following styrene exposure indicate involvement of oxidative stress in the molecular-response mechanism.

Nora Mörbt1, Iljana Mögel, Stefan Kalkhof, Ralph Feltens, Carmen Röder-Stolinski, Jiang Zheng, Carsten Vogt, Irina Lehmann, Martin von Bergen.   

Abstract

Styrene is a volatile organic compound that is widely used as an intermediate in many industrial settings. There are known adverse health effects at environmentally significant concentrations, but little is known about the molecular effect of exposure to styrene at sub-acute toxic concentrations. We exposed human lung epithelial cells, at a wide range of concentrations (1 mg/m(3)-10 g/m(3)), to styrene and analyzed the effects on the proteome level by 2-DE, where 1380 proteins spots were detected and 266 were identified unambiguously by MS. A set of 16 protein spots were found to be significantly altered due to exposure to styrene at environmentally significant concentrations of 1-10 mg/m(3) (0.2-2.3 ppm). Among these, superoxide dismutase as well as biliverdin reductase A could be correlated with the molecular pathway of oxidative stress, while eukaryotic translation initiation factor 5A-1, ezrin, lamin B2 and voltage-dependent anion channel 2 have been reported to be involved in apoptosis. Treatment with styrene also caused the formation of styrene oxide-protein adducts, specifically for thioredoxin reductase 1. These results underline the relevance of oxidative stress as a primary molecular response mechanism of lung epithelial cells to styrene exposure at indoor-relevant concentrations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19862763      PMCID: PMC3463241          DOI: 10.1002/pmic.200800836

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  68 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

Review 2.  The ALG-2/AIP-complex, a modulator at the interface between cell proliferation and cell death? A hypothesis.

Authors:  J Krebs; R Klemenz
Journal:  Biochim Biophys Acta       Date:  2000-12-20

Review 3.  Volatile organic compounds and indoor air.

Authors:  M Hodgson; H Levin; P Wolkoff
Journal:  J Allergy Clin Immunol       Date:  1994-08       Impact factor: 10.793

4.  Biliverdin reductase: a major physiologic cytoprotectant.

Authors:  David E Baranano; Mahil Rao; Christopher D Ferris; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

Review 5.  Lessons from Drosophila models of DJ-1 deficiency.

Authors:  Darren J Moore; Valina L Dawson; Ted M Dawson
Journal:  Sci Aging Knowledge Environ       Date:  2006-01-11

6.  Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression.

Authors:  K Banki; E Hutter; E Colombo; N J Gonchoroff; A Perl
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

7.  Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappa B activation.

Authors:  Kyu-Jin Park; Richard B Gaynor; Youn Tae Kwak
Journal:  J Biol Chem       Date:  2003-06-25       Impact factor: 5.157

8.  Volatile organic compounds cytotoxicity and expression of HSP72, HSP90 and GRP78 stress proteins in cultured human cells.

Authors:  F Croute; J Poinsot; Y Gaubin; B Beau; V Simon; J C Murat; J P Soleilhavoup
Journal:  Biochim Biophys Acta       Date:  2002-08-19

9.  Expressional patterns of chaperones in ten human tumor cell lines.

Authors:  Jae-Kyung Myung; Leila Afjehi-Sadat; Maureen Felizardo-Cabatic; Irene Slavc; Gert Lubec
Journal:  Proteome Sci       Date:  2004-12-14       Impact factor: 2.480

Review 10.  Heme oxygenase-1 and carbon monoxide in pulmonary medicine.

Authors:  Dirk-Jan Slebos; Stefan W Ryter; Augustine M K Choi
Journal:  Respir Res       Date:  2003-08-07
View more
  6 in total

1.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

2.  Structure-toxicity relationship study of para-halogenated styrene analogues in CYP2E1 transgenic cells.

Authors:  Jou-Ku Chung; Shuijie Shen; Zhiteng Jiang; Wei Yuan; Jiang Zheng
Journal:  Toxicol Lett       Date:  2012-02-16       Impact factor: 4.372

3.  Quantitative proteomics reveals altered expression of extracellular matrix related proteins of human primary dermal fibroblasts in response to sulfated hyaluronan and collagen applied as artificial extracellular matrix.

Authors:  Stephan A Müller; Anja van der Smissen; Margarete von Feilitzsch; Ulf Anderegg; Stefan Kalkhof; Martin von Bergen
Journal:  J Mater Sci Mater Med       Date:  2012-09-19       Impact factor: 3.896

4.  MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4.

Authors:  K Schramedei; N Mörbt; G Pfeifer; J Läuter; M Rosolowski; J M Tomm; M von Bergen; F Horn; K Brocke-Heidrich
Journal:  Oncogene       Date:  2011-02-14       Impact factor: 9.867

5.  DIGE proteome analysis reveals suitability of ischemic cardiac in vitro model for studying cellular response to acute ischemia and regeneration.

Authors:  Sina Haas; Heinz-Georg Jahnke; Nora Moerbt; Martin von Bergen; Seyedhossein Aharinejad; Olena Andrukhova; Andrea A Robitzki
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

6.  Volatile organic compounds enhance allergic airway inflammation in an experimental mouse model.

Authors:  Ulrike Bönisch; Alexander Böhme; Tibor Kohajda; Iljana Mögel; Nicole Schütze; Martin von Bergen; Jan C Simon; Irina Lehmann; Tobias Polte
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.